Indication
Treatment of moderate to severe dry eye disease (keratoconjuctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes.
Medicine details
- Medicine name:
- ciclosporin (Vevizye)
- SMC ID:
- SMC2873
- Pharmaceutical company
- Thea Pharmaceuticals
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Publication due date:
- 19 January 2026